Skip to main content
. 2022 Jun 2;54(2):316–327. doi: 10.3947/ic.2022.0049

Table 1. Baseline characteristics of the respondents.

Total (n = 326) Experience in managing COVID-19 patients (n = 216) No experience in managing COVID-19 patients (n = 110) P-value
Female Sex 107 (32.8) 67 (31.0) 40 (36.4) 0.331
Age
<30 92 (28.2) 62 (28.7) 30 (27.3) 0.309
30 - 39 196 (60.1) 132 (61.1) 64 (58.2) -
40 - 49 35 (10.7) 19 (8.8) 16 (14.6) -
50 - 59 3 (0.9) 3 (1.4) 0 (0.0) -
≥60 0 (0.0) 0 (0.0) 0 (0.0) -
Length of working experience, years
<5 197 (60.4) 134 (62.0) 63 (57.3) 0.603
6 - 15 110 (33.7) 71 (32.9) 39 (35.5) -
≥16 19 (5.8) 11 (5.1) 8 (7.3) -
Working area
Metropolitan area 111 (34.1) 92 (42.6) 19 (17.3) <0.001
Gangwon Province 15 (4.6) 7 (3.2) 8 (7.3) -
Chungcheong Province 59 (18.1) 42 (19.4) 17 (15.5) -
Jeolla Province 66 (20.3) 28 (13.0) 38 (34.6) -
Gyeongsang Province 70 (21.5) 45 (20.8) 25 (22.7) -
Jeju Province 5 (1.5) 2 (0.9) 3 (2.7) -
Residence type, during the COVID-19 outbreaka
Living with family members 257 (78.8) 172 (79.6) 85 (77.3) 0.622
Living with non-family members 2 (0.6) 2 (0.9) 0 (0.0) 0.552
Living alone 76 (23.3) 51 (23.6) 25 (22.7) 0.858
Underlying comorbidities
Existence of physical illnesses 71 (21.8) 49 (22.7) 22 (20.0) 0.579
Hypertension 7 (2.2) 4 (1.9) 3 (2.7) 0.692
Diabetes 2 (0.6) 2 (0.9) 0 (0.0) 0.551
Hyperlipidemia 3 (0.9) 2 (0.9) 1 (0.9) 1.000
Chronic liver disease 4 (1.2) 2 (0.9) 2 (1.8) 0.606
Chronic heart disease 3 (0.9) 1 (0.5) 2 (1.8) 0.264
Chronic pulmonary disease 1 (0.3) 1 (0.5) 0 (0.0) 1.000
Malignancy 1 (0.3) 0 (0.0) 1 (0.9) 0.337
Musculoskeletal disorder 59 (18.1) 44 (20.4) 15 (13.6) 0.135
Existence of mental illnesses 7 (2.1) 4 (1.9) 3 (2.7) 0.692
Depression 1 (0.3) 1 (0.5) 0 (0.0) 1.000
Anxiety 4 (1.2) 2 (0.9) 2 (1.8) 0.606
Insomnia 3 (0.9) 2 (0.9) 1 (0.9) 1.000

Values are presented as number (%).

aThis question requested the respondent to select multiple items.

COVID-19, coronavirus disease 2019.